Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Assessment of early changes in 3H-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression

Figure 4

Comparison of tumor size between pre- and post-treatments in each group. Control, Gefitinib 100, and Gefitinib 200 indicate the control group, group treated with 100 mg/kg gefitinib, and group treated with 200 mg/kg gefitinib, respectively. Pre- and post-treatment indicate before and 3 days after the start of treatment with gefitinib; Values given are mean ± SD.

Back to article page